FDA Clearance Tracker · P930016
VISX EXCIMER LASER SYSTEM MODELS B AND C
Last checked: Nov 20, 2026Latest source record: Mar 27, 1996 (this decision)Source: openFDAMethods & limitations
Decided
Mar 27, 1996
Approved
Time to decision
1,016 days
Received Jun 15, 1993. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P930016
- Device name
- VISX EXCIMER LASER SYSTEM MODELS B AND C
- Applicant
- Amo Manufacturing USA, LLC
- Applicant location
- Milpitas, CA
- Received
- Jun 15, 1993
- Decided
- Mar 27, 1996
- Decision
- Approved
- Supplements
- 62 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Excimer laser system (LZS)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE VISX EXCIMER LASER SYSTEM (MODELS B AND C)
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LZS. The earliest in FDA's data is P910067, decided Mar 10, 1995.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Amo Manufacturing USA, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K223838 · Decided Apr 12, 2023 · 111 days after receipt
Device type: Ophthalmic Femtosecond Laser (OOE) · Ophthalmology
K220516 · Decided May 17, 2022 · 83 days after receipt
Device type: Ophthalmic Femtosecond Laser (OOE) · Ophthalmology
K210701 · Decided Apr 7, 2021 · 29 days after receipt
Device type: Ophthalmic Femtosecond Laser (OOE) · Ophthalmology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.